Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9876)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 18, 2016 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Loustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P. Ribavirin: Past, present and future. World J Hepatol 2016; 8(2): 123-130 [PMID: 26807208 DOI: 10.4254/wjh.v8.i2.123] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i2/123.htm |
| Number | Citing Articles |
| 1 |
Joshua Casaos, Sakibul Huq, Tarik Lott, Raphael Felder, John Choi, Noah Gorelick, Michael Peters, Yuanxuan Xia, Russell Maxwell, Tianna Zhao, Chenchen Ji, Thomas Simon, Julie Sesen, Sarah J. Scotland, Richard E. Kast, Jeffrey Rubens, Eric Raabe, Charles G. Eberhart, Eric M. Jackson, Henry Brem, Betty Tyler, Nicolas Skuli. Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors. Oncotarget 2018; 9(8): 8054 doi: 10.18632/oncotarget.23883
|
| 2 |
Vishvanath Tiwari. Denovo designing, retrosynthetic analysis, and combinatorial synthesis of a hybrid antiviral (VTAR-01) to inhibit the interaction of SARS-CoV2 spike glycoprotein with human angiotensin-converting enzyme 2. Biology Open 2020; doi: 10.1242/bio.054056
|
| 3 |
Vishvanath Tiwari. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus. International Journal of Biological Macromolecules 2021; 171: 358 doi: 10.1016/j.ijbiomac.2020.12.223
|
| 4 |
Alina Tanase, Aniko Manea, Alexandra Denisa Scurtu, Lavinia Melania Bratu, Doina Chioran, Alina Dolghi, Iren Alexoi, Hazzaa AAbed, Voichita Lazureanu, Cristina Adriana Dehelean. The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment. Medicina 2022; 58(2): 261 doi: 10.3390/medicina58020261
|
| 5 |
Adrienne O’Donnell, Nathan Pham, Leandra Battisti, Rachel Epstein, David Nunes, Deirdre Sawinski, Sara Lodi, Chen-Hua Liu. Estimating the causal effect of treatment with direct-acting antivirals on kidney function among individuals with hepatitis C virus infection. PLOS ONE 2022; 17(5): e0268478 doi: 10.1371/journal.pone.0268478
|
| 6 |
Longping V. Tse, Rita M. Meganck, Rachel L. Graham, Ralph S. Baric. The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00658
|
| 7 |
Christina Wangen, Andrea Raithel, Julia Tillmanns, Christian Gege, Alexandra Herrmann, Daniel Vitt, Hella Kohlhof, Manfred Marschall, Friedrich Hahn. Validation of nuclear receptor RORγ isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels. Antiviral Research 2024; 221: 105769 doi: 10.1016/j.antiviral.2023.105769
|
| 8 |
Julia M. Smyk, Anna Majewska. Favipiravir in the Battle with Respiratory Viruses. Mini-Reviews in Medicinal Chemistry 2022; 22(17): 2224 doi: 10.2174/1389557522666220218122744
|
| 9 |
Carina Sperotto Librelotto, Daniel Simon, Ana Paula de Souza, Mário Reis Álvares-da-Silva, Rafael Rodrigues Dihl. Chromosomal instability and cytotoxicity induced by ribavirin: comparative analysis in cell lines with different drug-metabolizing profiles. Drug and Chemical Toxicology 2019; 42(4): 343 doi: 10.1080/01480545.2017.1405970
|
| 10 |
Pablo Zubiaur, Dora Koller, Miriam Saiz‐Rodríguez, Marcos Navares‐Gómez, Francisco Abad‐Santos. Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19). Clinical and Translational Science 2020; 13(6): 1023 doi: 10.1111/cts.12866
|
| 11 |
Jing Jin, Wei Xiang, Shuang Wu, Min Wang, Meifang Xiao, Ali Deng. Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer. Biochemical and Biophysical Research Communications 2019; 510(4): 580 doi: 10.1016/j.bbrc.2019.01.117
|
| 12 |
Elenilson F da Silva, Krist Helen Antunes Fernandes, Denise Diedrich, Jessica Gotardi, Marcia Silvana Freire Franco, Carlos Henrique Tomich de Paula da Silva, Ana Paula Duarte de Souza, Simone Cristina Baggio Gnoatto. New triazole-substituted triterpene derivatives exhibiting anti-RSV activity: synthesis, biological evaluation, and molecular modeling. Beilstein Journal of Organic Chemistry 2022; 18: 1524 doi: 10.3762/bjoc.18.161
|
| 13 |
F. A. Khaliullin, E. E. Klen, N. N. Makarova. Thietanyl Protection in the Synthesis of 5-Aryloxy(sulfonyl)-3-bromo-1,2,4-triazoles. Russian Journal of Organic Chemistry 2018; 54(12): 1856 doi: 10.1134/S1070428018120242
|
| 14 |
J. Cao, X. Sun, X. Zhang, D. Chen. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma. Clinical and Translational Oncology 2018; 20(6): 761 doi: 10.1007/s12094-017-1786-z
|
| 15 |
Debora Obergfäll, Markus Wild, Mona Sommerer, Malena Barillas Dahm, Jintawee Kicuntod, Julia Tillmanns, Melanie Kögler, Josephine Lösing, Kishore Dhotre, Regina Müller, Christina Wangen, Sabrina Wagner, Quang V. Phan, Lüder Wiebusch, Katarína Briestenská, Jela Mistríková, Lauren Kerr-Jones, Richard J. Stanton, Sebastian Voigt, Friedrich Hahn, Manfred Marschall. Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies. Pharmaceutics 2024; 16(9): 1238 doi: 10.3390/pharmaceutics16091238
|
| 16 |
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Upadhyayula Suryanarayana Murty, Sucheta Banerjee Kurundkar, Debjani Roy, Pankaj Joshi, Dhananjay Sable, Yogendra Kumar Choudhary, Prashant Kesharwani, Amit Alexander. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respiratory Medicine 2022; 191: 106192 doi: 10.1016/j.rmed.2020.106192
|
| 17 |
Hazael Ramiro Ceja-Gálvez, Francisco Israel Renteria-Flores, Ferdinando Nicoletti, Jorge Hernández-Bello, Gabriela Macedo-Ojeda, José Francisco Muñoz-Valle. Severe COVID-19: Drugs and Clinical Trials. Journal of Clinical Medicine 2023; 12(8): 2893 doi: 10.3390/jcm12082893
|
| 18 |
Robert W. Shafer, Guy Boivin, Anita Y. M. Howe, Sunwen Chou. ClinMicroNow. 2023; : 1 doi: 10.1002/9781683674849.mcm0115
|
| 19 |
Pierre Sierocki, Krystal Gaillard, Ruben Arturo Arellano Reyes, Chloé Donnart, Emilie Lambert, Sandrine Grosse, Laurence Arzel, Arnaud Tessier, Jerome Guillemont, Monique Mathé-Allainmat, Jacques Lebreton. Synthesis of novel C-nucleoside analogues bearing an anomeric cyano and a 1,2,3-triazole nucleobase as potential antiviral agents. Organic & Biomolecular Chemistry 2022; 20(13): 2715 doi: 10.1039/D1OB02451E
|
| 20 |
Sujit Kumar Debnath, Monalisha Debnath, Rohit Srivastava. Opportunistic etiological agents causing lung infections: emerging need to transform lung-targeted delivery. Heliyon 2022; 8(12): e12620 doi: 10.1016/j.heliyon.2022.e12620
|
| 21 |
Frederick Hansen, Michael A. Jarvis, Heinz Feldmann, Kyle Rosenke. Lassa Virus Treatment Options. Microorganisms 2021; 9(4): 772 doi: 10.3390/microorganisms9040772
|
| 22 |
Ran Huang, Qiong Dai, Ruixue Yang, Yi Duan, Qi Zhao, Johannes Haybaeck, Zhihui Yang. A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.817916
|
| 23 |
Omer Basar, Francis Dailey, Erica Dailey, Veysel Tahan, Ebubekir Daglilar. Interferon-Induced Crohn’s Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection. Cureus 2021; doi: 10.7759/cureus.15568
|
| 24 |
Humzah Iqbal, Bilal Fazal Mehmood, Aalam Sohal, Marina Roytman. Hepatitis E infection: A review. World Journal of Virology 2023; 12(5): 262-271 doi: 10.5501/wjv.v12.i5.262
Abstract(500) |
Core Tip(530) |
Full Article(HTML)(2750)
|
Full Article with Cover (PDF)-2096K(107)
|
Full Article (Word)-834K(19)
|
Audio-712K(1)
|
Peer-Review Report-179K(142)
|
Answering Reviewers-197K(65)
|
Full Article (PDF)-1875K(260)
|
Full Article (XML)-152K(69)
|
Times Cited (5)
|
Total Visits (6160)
|
Open
|
| 25 |
Abdel-moniem S Hassan, Abdo A Elfiky, Alaa M Elgohary.
Triple
in Silico
Targeting of IMPDH Enzyme and RNA-Dependent RNA Polymerase of Both SARS-CoV-2 and
Rhizopus Oryzae
. Future Microbiology 2024; 19(1): 9 doi: 10.2217/fmb-2023-0103
|
| 26 |
Javed Khan, Anjali Rani, Mohd Aslam, R.S. Maharia, Garima Pandey, Bhaskara Nand. Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review. Tetrahedron 2024; 162: 134122 doi: 10.1016/j.tet.2024.134122
|
| 27 |
Suyin Ge, Qingqing Zhang, Yonglin Chen, Yizhen Tian, Ruiying Yang, Xu Chen, Fang Li, Baolai Zhang. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation. Toxicology and Applied Pharmacology 2021; 415: 115450 doi: 10.1016/j.taap.2021.115450
|
| 28 |
Hala A. Abdulhassan, Basil A. Saleh, Dalal Harkati, Hadjer Khelfaoui, Natalie L. Hewitt, Gamal A. El-Hiti. In Silico Pesticide Discovery for New Anti-Tobacco Mosaic Virus Agents: Reactivity, Molecular Docking, and Molecular Dynamics Simulations. Applied Sciences 2022; 12(6): 2818 doi: 10.3390/app12062818
|
| 29 |
Qikai Sun, Quanquan Wang, Wenzhuo Qin, Kaiyu Jiang, Gang He, Ming Joo Koh, Gong Chen. N-glycoside synthesis through combined copper- and photoredox-catalysed N-glycosylation of N-nucleophiles. Nature Synthesis 2024; 3(5): 623 doi: 10.1038/s44160-024-00496-7
|
| 30 |
Tangella Nagendra Prasad, Yeruva Pavankumar Reddy, Poorna Chandrasekhar Settipalli, Vadiga Shanthi Kumar, Eeda Koti Reddy, Shaik Firoj Basha, Shaik Anwar. Synthesis oftransN-Substituted Pyrrolidine Derivatives Bearing 1,2,4- triazole Ring. Current Organic Synthesis 2022; 19(5): 578 doi: 10.2174/1570179419666211230094334
|
| 31 |
Lin Wang, Zheyi Wang, Zhihua Yang, Xingwang Wang, Liping Yan, Jianxiong Wu, Yue Liu, Baohui Fu, Hongtao Yang. Potential common mechanism of four Chinese patent medicines recommended by diagnosis and treatment protocol for COVID-19 in medical observation period. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.874611
|
| 32 |
F Volpin, J Casaos, J Sesen, A Mangraviti, J Choi, N Gorelick, J Frikeche, T Lott, R Felder, S J Scotland, T S K Eisinger-Mathason, H Brem, B Tyler, N Skuli. Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic. Oncogene 2017; 36(21): 3037 doi: 10.1038/onc.2016.457
|
| 33 |
Jorge A. Soto, Ricardo A. Loaiza, Sebastián Echeverría, Robinson A. Ramírez, Alexis M. Kalergis. Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants. Expert Opinion on Pharmacotherapy 2023; 24(10): 1143 doi: 10.1080/14656566.2023.2213433
|
| 34 |
Jianguo Chen, Xiaoming Xu, Junjun Chen. Clinically relevant concentration of anti-viral drug ribavirin selectively targets pediatric osteosarcoma and increases chemosensitivity. Biochemical and Biophysical Research Communications 2018; 506(3): 604 doi: 10.1016/j.bbrc.2018.10.124
|
| 35 |
Debosmita Sanyal, Binay Chaubey. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges. Future Virology 2024; 19(2-4): 127 doi: 10.2217/fvl-2023-0169
|
| 36 |
Lautaro A. M. Giaimo, Leticia Lafuente, Romina N. Fernández Varela, Matías L. Nóbile, Adolfo M. Iribarren, Elizabeth S. Lewkowicz. Synthesis of 4‐Iodoimidazole Nucleosides: A Biocatalyzed Whole Cell Approach. European Journal of Organic Chemistry 2025; doi: 10.1002/ejoc.202400950
|
| 37 |
Viola Guardigni, Lorenzo Badia, Matteo Conti, Matteo Rinaldi, Rita Mancini, Pierluigi Viale, Gabriella Verucchi. Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals. World Journal of Hepatology 2017; 9(34): 1270-1277 doi: 10.4254/wjh.v9.i34.1270
|
| 38 |
Giuseppe M Marcello, Kali A Holder, Sara Hallager, Benjamin B Norton, Kay A Backues, Anna E Tyler, Ayo Zeitlin, Evan Murray-Hiteshew, Suzan Murray. Intralesional application of ribavirin in two American flamingos (Phoenicopterus ruber) with poxvirus infection. Journal of Comparative Pathology 2023; 201: 49 doi: 10.1016/j.jcpa.2022.11.004
|
| 39 |
Robert W. Shafer, Guy Boivin, Anita Y. M. Howe, Sunwen Chou. ClinMicroNow. 2023; : 1 doi: 10.1002/9781683670438.mcm0115
|
| 40 |
Qudus Olajide Lawal, Joseph Okoeguale, Sebastine Oseghae Oiwoh, ThankGod Akhigbe, Reuben Agbons Eifediyi, Sylvanus Akhalufo Okogbenin. Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge. Tropical Medicine and Health 2024; 52(1) doi: 10.1186/s41182-024-00609-0
|
| 41 |
Yuxi Guo, Xuefeng Chen, Pin Gong. Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus. International Journal of Biological Macromolecules 2021; 183: 1753 doi: 10.1016/j.ijbiomac.2021.05.139
|
| 42 |
Aditya Upadhyay, Awanish Kumar, Monu Verma. Pathogenic Viruses and Armamentarium Design. 2024; : 79 doi: 10.1016/B978-0-443-15241-2.00005-3
|
| 43 |
Anirudh Pratap Singh Raman, Mohd. Aslam, Amardeep Awasthi, Anas Ansari, Pallavi Jain, Kashmiri Lal, Indra Bahadur, Prashant Singh, Kamlesh Kumari. An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential. Molecular Diversity 2025; 29(1): 899 doi: 10.1007/s11030-024-10858-0
|
| 44 |
Sushmita Patra, Rout George Kerry, Ganesh Kumar Maurya, Bijayananda Panigrahi, Swati Kumari, Jyoti Ranjan Rout. Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.02098
|
| 45 |
Meijun Lu, Qing-Bin Lu, John F. Honek. Squarate-based carbocyclic nucleosides: Syntheses, computational analyses and anticancer/antiviral evaluation. Bioorganic & Medicinal Chemistry Letters 2017; 27(2): 282 doi: 10.1016/j.bmcl.2016.11.058
|
| 46 |
Zhihua Hu, Lanfang Zhen, Qin Li, Qi Han, Qinquan Hua. Ribavirin sensitizes nasopharyngeal carcinoma to 5-fluorouracil through suppressing 5-fluorouracil-induced ERK-dependent-eIF4E activation. Biochemical and Biophysical Research Communications 2019; 513(4): 862 doi: 10.1016/j.bbrc.2019.04.053
|
| 47 |
Prateek Kumar, Taniya Bhardwaj, Ankur Kumar, Bhuvaneshwari R. Gehi, Shivani K. Kapuganti, Neha Garg, Gopal Nath, Rajanish Giri. Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study. Journal of Biomolecular Structure and Dynamics 2022; 40(7): 3170 doi: 10.1080/07391102.2020.1845976
|
| 48 |
Eric J. Wang, Jay Karri, Nuj Tontisirin, Steven P. Cohen. Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms. The Korean Journal of Pain 2023; 36(3): 281 doi: 10.3344/kjp.23129
|
| 49 |
Ehab S El Desoky, Alaa T Abdelhafez, Jessica Cusato, Sherif I Kamel, Abeer MR Hussein, Amedeo De Nicolo, Giovanni Di Perri, Antonio D'Avolio. The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin‐induced anaemia in chronic hepatitis C Egyptian patients. Clinical and Experimental Pharmacology and Physiology 2017; 44(9): 965 doi: 10.1111/1440-1681.12786
|
| 50 |
Vijayakumar Rajendran, Saravanan Kandasamy, Ankita Gupta, Killivalavan Asaithambi, Ashish Runthala, Jagannathan Selvaraj, Shivanandappa Kukkaler Channappa. Drugs and a Methodological Compendium. 2023; : 399 doi: 10.1007/978-981-19-7952-1_15
|
| 51 |
Eloi R Verrier, Amélie Weiss, Charlotte Bach, Laura Heydmann, Vincent Turon-Lagot, Arnaud Kopp, Houssein El Saghire, Emilie Crouchet, Patrick Pessaux, Thomas Garcia, Patrick Pale, Mirjam B Zeisel, Camille Sureau, Catherine Schuster, Laurent Brino, Thomas F Baumert. Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets. Gut 2020; 69(1): 158 doi: 10.1136/gutjnl-2018-317065
|
| 52 |
Sandip N. Badeliya, Ishan I. Panchal, Bibhuranjan Panigrahi, C. N. Patel. In Silico Analysis, Synthesis, and Biological Evaluation of Triazole Derivatives as H1 Receptor Antagonist. Current Drug Discovery Technologies 2021; 18(4): 492 doi: 10.2174/1568009620666200421082221
|
| 53 |
Ojasvi Gupta, Tathagata Pradhan, Gita Chawla. An updated review on diverse range of biological activities of 1,2,4-triazole derivatives: Insight into structure activity relationship. Journal of Molecular Structure 2023; 1274: 134487 doi: 10.1016/j.molstruc.2022.134487
|
| 54 |
Jan Rahmig, Arne Grey, Marco Berning, Jochen Schaefer, Martin Lesser, Heinz Reichmann, Volker Puetz, Kristian Barlinn, Timo Siepmann. Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report. BMC Neurology 2020; 20(1) doi: 10.1186/s12883-020-01952-5
|
| 55 |
Mohammad Amin Abbasi, Ehsan Rikhtegar, Shahin Keshtkar Rajabi. A Patient with Brucella with initial Manifestations similar to Crimean Congo Fever. Journal of Research in Applied and Basic Medical Sciences 2023; 9(4): 229 doi: 10.61186/rabms.9.4.229
|
| 56 |
Michael H. J. Rhodin, Nicole V. McAllister, Jonathan Castillo, Sarah L. Noton, Rachel Fearns, In Jong Kim, Jianming Yu, Thomas P. Blaisdell, Joseph Panarese, Brian C. Shook, Yat Sun Or, Bryan Goodwin, Kai Lin, Mark Krystal. EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model. PLOS Pathogens 2021; 17(3): e1009428 doi: 10.1371/journal.ppat.1009428
|
| 57 |
Liang Liu, Sixun Guo, Chunli Che, Quanming Su, Deqiu Zhu, Xin Hai. Improved HPLC method for the determination of ribavirin concentration in red blood cells and its application in patients with COVID‐19. Biomedical Chromatography 2022; 36(7) doi: 10.1002/bmc.5370
|
| 58 |
DongHoon Yu, Sabrina Wagner, Martin Schütz, Yeejin Jeon, Mooyoung Seo, Jaeseung Kim, Nadine Brückner, Jintawee Kicuntod, Julia Tillmanns, Christina Wangen, Friedrich Hahn, Benedikt B. Kaufer, Frank Neipel, Jan Eickhoff, Bert Klebl, Kiyean Nam, Manfred Marschall. An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity. Pharmaceutics 2024; 16(2): 158 doi: 10.3390/pharmaceutics16020158
|